Altman Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-14,143	Closed	-$1.53K	–	82
2018 Q2	$1.53K	Buy	+14,143	New	+$1.53K	1.4%	42